Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential supramolecular assembly of tannic acid and phenylboronic acid copolymers enabling enhanced cancer immunotherapy.

Journal of materials chemistry. B·2026
Same author

Author Correction: Semantic memory disorganization linked to social functioning in patients with schizophrenia.

Schizophrenia (Heidelberg, Germany)·2026
Same author

Comparative study of Japanese nationwide epidemiological studies of myasthenia gravis using datasets of 2006 and 2018.

PloS one·2025
Same author

Semantic memory disorganization linked to social functioning in patients with schizophrenia.

Schizophrenia (Heidelberg, Germany)·2025
Same author

Autistic trait severity in early schizophrenia: Role in subjective quality of life and social functioning.

Schizophrenia research·2024
Same author

Prevalence of, and Disability Due to, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Japan by the Fifth Nationwide Survey.

Neurology·2024
Same journal

Inflammasomes in Intestinal Inflammation: Guardians of Mucosal Homeostasis, Amplifiers of Disease, and Targets for Intervention.

Internal medicine (Tokyo, Japan)·2026
Same journal

Late-diagnosed Nonclassical 21-hydroxylase Deficiency in Two Elderly Men with Adrenal Incidentalomas: Clinical Clues to the Underlying Diagnosis.

Internal medicine (Tokyo, Japan)·2026
Same journal

Fish Bone Aspiration Presenting as Chronic Cough and Mimicking Asthma.

Internal medicine (Tokyo, Japan)·2026
Same journal

Successful Alternate-day Osimertinib Administration with Desensitization Following Osimertinib-induced Hepatotoxicity and Neutropenia in a Case of EGFR-mutant Lung Cancer.

Internal medicine (Tokyo, Japan)·2026
Same journal

Marked Hyperbilirubinemia in a Patient with Intrahepatic Cholestasis of Pregnancy and a UGT1A1 Polymorphism: A Case Report.

Internal medicine (Tokyo, Japan)·2026
Same journal

Successful Postpartum CAR T-cell Salvage Therapy for Primary Mediastinal Large B-cell Lymphoma with Residual Disease after R-CHOP During Pregnancy.

Internal medicine (Tokyo, Japan)·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K

Biomarkers for multiple sclerosis.

Ryo Tomioka1, Makoto Matsui

  • 1Department of Neurology, Kanazawa Medical University, Japan.

Internal Medicine (Tokyo, Japan)
|March 4, 2014
PubMed
Summary
This summary is machine-generated.

Biomarkers offer precise insights into multiple sclerosis (MS) immune responses and treatment effects. Cerebrospinal fluid biomarkers are definitive, while serum markers provide feasible monitoring for disease activity.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

5.3K

Related Experiment Videos

Last Updated: May 2, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

5.3K

Area of Science:

  • Neuroimmunology
  • Biomarker Discovery
  • Multiple Sclerosis Research

Background:

  • Magnetic resonance imaging (MRI) is crucial for diagnosing multiple sclerosis (MS) and assessing disease activity.
  • Biomarkers offer a more accurate understanding of immune responses, demyelination, and treatment efficacy in MS patients.

Purpose of the Study:

  • To explore the utility of various biomarkers in diagnosing and monitoring multiple sclerosis (MS).
  • To differentiate the diagnostic and monitoring capabilities of serum versus cerebrospinal fluid (CSF) biomarkers.
  • To identify potential biomarkers for understanding MS pathogenesis and guiding new treatment strategies.

Main Methods:

  • Analysis of serum and cerebrospinal fluid (CSF) biomarkers, including oligoclonal IgG bands, adhesion molecules, matrix metalloproteinase-9, complement factor H, and cytokine/chemokine levels (IL-8, IL-12, IL-17, CCL3, CCL5, CXCL10).
  • Evaluation of immune cell proportions (Th1/Th2 cells, Th1, CD4(+)CD25(+) cells) in blood and CSF using flow cytometry.
  • Comparison of biomarker data with disease activity and relapse status in MS patients.

Main Results:

  • Oligoclonal IgG bands in CSF are important for MS diagnosis.
  • Serum biomarkers like adhesion molecules and MMP-9, along with Th1/Th2 cell ratios, show potential for monitoring disease activity.
  • Elevated levels of specific cytokines and chemokines (IL-8, IL-12, IL-17, CCL3, CCL5, CXCL10) in CSF indicate active MS.
  • Flow cytometry reveals increased Th1 and CD4(+)CD25(+) cells in CSF during relapses.

Conclusions:

  • Biomarkers provide critical information on MS pathogenesis, disease activity, and treatment response.
  • CSF biomarkers offer definitive diagnostic and activity indicators, though accessibility is limited.
  • Serum biomarkers and immune cell analysis present feasible options for monitoring MS.
  • Future research will focus on identifying biomarkers associated with tissue repair for novel therapeutic targets.